The TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis of tumor cells but not most normal cells. Its role in hepatic cell death and hepatic diseases is not clear. In vitro studies suggest that murine hepatocytes are not sensitive to TRAIL-induced apoptosis, indicating that TRAIL may not mediate hepatic cell death. Using two experimental models of hepatitis, we found that hepatic cell death in vivo was dramatically reduced in TRAIL-deficient mice and mice treated with a blocking TRAIL receptor. Although both TRAIL and its death receptor 5 were constitutively expressed in the liver, TRAIL expression by immune cells alone was sufficient to restore the sensitivity of TRAIL-deficient mice to hepatitis. Thus, TRAIL plays a crucial role in hepatic cell death and hepatic inflammation.
Shi-Jun Zheng, Pu Wang, Galit Tsabary, Youhai H. Chen
Title and authors | Publication | Year |
---|---|---|
Transplantation of chemically induced liver progenitors in Nagase analbuminemic rats under liver regenerative stimulus
Fukumoto M, Soyama A, Miyamoto D, Hara T, Matsushima H, Imamura H, Yamashita M, Adachi T, Kanetaka K, Eguchi S |
Regenerative Therapy | 2025 |
TNF-Related Apoptosis-Inducing Ligand: Non-Apoptotic Signalling.
Guerrache A, Micheau O |
Cells | 2024 |
RANK–RANKL–OPG Axis in MASLD: Current Evidence Linking Bone and Liver Diseases and Future Perspectives
Monti F, Perazza F, Leoni L, Stefanini B, Ferri S, Tovoli F, Zavatta G, Piscaglia F, Petroni ML, Ravaioli F |
International Journal of Molecular Sciences | 2024 |
Advancing Systemic Therapy in Chondrosarcoma: New Horizons
Li KH, Gulia A, Duffaud F, Jones RL |
Oncology and Therapy | 2024 |
LIGHT Amplification by NF-κB Contributes to TLR3 Signaling Pathway-Induced Acute Hepatitis
Lai D, Lv Z, Lu X, Shang P, Geng Y, Wang P |
Mediators of Inflammation | 2023 |
Inhibition of immune checkpoints PD-1, CTLA-4, and IDO1 coordinately induces immune-mediated liver injury in mice
T Affolter, HP Llewellyn, DW Bartlett, Q Zong, S Xia, V Torti, C Ji, P Mukhopadhyay |
PloS one | 2019 |
Preclinical studies of a death receptor 5 fusion protein that ameliorates acute liver failure
Q Chen, P Wang, Q Zhang, M Xia, G Zhang, J Li, E Shen, YH Chen, X Wan |
Journal of Molecular Medicine | 2019 |
Non‐apoptotic TRAIL function modulates NK cell activity during viral infection
LC Alves, MD Berger, T Koutsandreas, N Kirschke, C Lauer, R Spörri, A Chatziioannou, N Corazza, P Krebs |
EMBO reports | 2019 |
Hepatoprotective Effect of San-Cao Granule on Con A-Induced Liver Injury in Mice and Mechanisms of Action Exploration
YX Yang, P Zhang, Y Wang, S Wei, L Zhang, J Wang, X Lu, H Zhou, R Li, J Wen, X Zhou, H Li, K Li, Y Zhao |
Frontiers in pharmacology | 2018 |
CEACAM1 in Liver Injury, Metabolic and Immune Regulation
A Horst, S Najjar, C Wagener, G Tiegs |
International journal of molecular sciences | 2018 |
Combined application of Embelin and tumor necrosis factor-related apoptosis-inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase-induced apoptosis.
Qian H, Chen Y, Huang T, Liu T, Li X, Jiang G, Zhang W, Cheng S, Li P |
Oncology Letters | 2018 |
Nature of Host Immunity during Hepatitis B Virus Infection and designing Immune Therapy.
Mf Akbar S, Al-Mahtab M, I Khan S |
Euroasian Journal of Hepato-Gastroenterology | 2018 |
RIPK1 protects hepatocytes from death in Fas-induced hepatitis
A Filliol, M Farooq, C Piquet-Pellorce, V Genet, MT Dimanche-Boitrel, P Vandenabeele, MJ Bertrand, M Samson, JL Seyec |
Scientific Reports | 2017 |
The apoptotic mechanisms of MT-6, a mitotic arrest inducer, in human ovarian cancer cells
MC Chen, YC Kuo, CM Hsu, YL Chen, CC Shen, CM Teng, SL Pan |
Scientific Reports | 2017 |
Bcl-2 degradation is an additional pro-apoptotic effect of polo-like kinase inhibition in cholangiocarcinoma cells
S Sydor, S Jafoui, L Wingerter, S Swoboda, JC Mertens, G Gerken, A Canbay, A Paul, CD Fingas |
World journal of gastroenterology : WJG | 2017 |
Protective Effect of Akkermansia muciniphila against Immune-Mediated Liver Injury in a Mouse Model
W Wu, L Lv, D Shi, J Ye, D Fang, F Guo, Y Li, X He, L Li |
Frontiers in microbiology | 2017 |
Analyzing the innate immunity of NIH hairless mice and the impact of gut microbial polymorphisms on Listeria monocytogenes infection
ZH Ji, WZ Ren, W Gao, Y Hao, W Gao, J Chen, FS Quan, JP Hu, B Yuan |
Oncotarget | 2017 |
Cancer preventive effect of recombinant TRAIL by ablation of oncogenic inflammation in colitis-associated cancer rather than anticancer effect
JY Kim, YM Kim, JM Park, YM Han, KC Lee, KB Hahm, S Hong |
Oncotarget | 2017 |
Crosstalk of liver immune cells and cell death mechanisms in different murine models of liver injury and its clinical relevance
Khan HA, Ahmad MZ, Khan JA, Arshad MI |
Hepatobiliary & Pancreatic Diseases International | 2017 |
Super natural killer cells that target metastases in the tumor draining lymph nodes
S Chandrasekaran, MF Chan, J Li, MR King |
Biomaterials | 2016 |
Questions and controversies: the role of necroptosis in liver disease
L Dara, ZX Liu, N Kaplowitz |
Cell Death Discovery | 2016 |
The chemical inhibitors of cellular death, PJ34 and Necrostatin-1, down-regulate IL-33 expression in liver
MI Arshad, C Piquet-Pellorce, A Filliol, A L’Helgoualc’h, C Lucas-Clerc, S Jouan-Lanhouet, MT Dimanche-Boitrel, M Samson |
Journal of Molecular Medicine | 2015 |
Cinnabar-Induced Subchronic Renal Injury Is Associated with Increased Apoptosis in Rats
Y Wang, D Wang, J Wu, B Wang, X Gao, L Wang, H Ma |
BioMed Research International | 2015 |
Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles
J Li, Y Ai, L Wang, P Bu, CC Sharkey, Q Wu, B Wun, S Roy, X Shen, MR King |
Biomaterials | 2015 |
HCV and HIV co-infection: mechanisms and management
JY Chen, ER Feeney, RT Chung |
Nature Reviews Gastroenterology & Hepatology | 2014 |
The C5a Anaphylatoxin Receptor (C5aR1) Protects against Listeria monocytogenes Infection by Inhibiting Type 1 IFN Expression
DG Calame, SL Mueller-Ortiz, JE Morales, RA Wetsel |
Journal of immunology (Baltimore, Md. : 1950) | 2014 |
Esophageal cancer-selective expression of TRAIL mediated by MREs of miR-143 and miR-122.
Zhou K, Yan Y, Zhao S |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine | 2014 |
TRAIL (TNF-related apoptosis-inducing ligand) regulates adipocyte metabolism by caspase-mediated cleavage of PPARgamma
M Keuper, IW Asterholm, PE Scherer, MA Westhoff, P Möller, KM Debatin, G Strauss, M Wabitsch, P Fischer-Posovszky |
Cell Death and Disease | 2013 |
Annexin V-TRAIL fusion protein is a more sensitive and potent apoptotic inducer for cancer therapy
F Qiu, M Hu, B Tang, X Liu, H Zhuang, J Yang, ZC Hua |
Scientific Reports | 2013 |
NK cells: a double-edged sword in chronic hepatitis B virus infection
MK Maini, D Peppa |
Frontiers in immunology | 2013 |
Blockade of Death Ligand TRAIL Inhibits Renal Ischemia Reperfusion Injury
T Adachi, N Sugiyama, T Gondai, H Yagita, T Yokoyama |
ACTA HISTOCHEMICA ET CYTOCHEMICA | 2013 |
Resistance to TRAIL and how to surmount it
D Maksimovic-Ivanic, S Stosic-Grujicic, F Nicoletti, S Mijatovic |
Immunologic Research | 2012 |
TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation
S Jouan-Lanhouet, MI Arshad, C Piquet-Pellorce, C Martin-Chouly, GL Moigne-Muller, FV Herreweghe, N Takahashi, O Sergent, D Lagadic-Gossmann, P Vandenabeele, M Samson, MT Dimanche-Boitrel |
Cell Death and Differentiation | 2012 |
The role of innate immunity in HBV infection
Q Han, C Zhang, J Zhang, Z Tian |
Seminars in Immunopathology | 2012 |
HIV-1 Coinfection and Morphine Coexposure Severely Dysregulate Hepatitis C Virus-Induced Hepatic Proinflammatory Cytokine Release and Free Radical Production: Increased Pathogenesis Coincides with Uncoordinated Host Defenses
N El-Hage, SM Dever, S Fitting, T Ahmed, KF Hauser |
Journal of virology | 2011 |
TNF superfamily: a growing saga of kidney injury modulators
MD Sanchez-Niño, A Benito-Martin, S Gonçalves, AB Sanz, AC Ucero, MC Izquierdo, AM Ramos, S Berzal, R Selgas, M Ruiz-Ortega, J Egido, A Ortiz |
Mediators of Inflammation | 2010 |
Predominant antitumor effects by fully human anti-TRAIL-receptor2 (DR5) monoclonal antibodies in human glioma cells in vitro and in vivo
M Nagane, S Shimizu, E Mori, S Kataoka, Y Shiokawa |
Neuro-Oncology | 2010 |
Control of death receptor ligand activity by posttranslational modifications
R Weinlich, T Brunner, GP Amarante-Mendes |
Cellular and Molecular Life Sciences | 2010 |
Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer
T Trarbach, M Moehler, V Heinemann, CH Köhne, M Przyborek, C Schulz, V Sneller, G Gallant, S Kanzler |
British Journal of Cancer | 2010 |
Sepsis-Induced Apoptosis Leads to Active Suppression of Delayed-Type Hypersensitivity by CD8 + Regulatory T Cells through a TRAIL-Dependent Mechanism
J Unsinger, H Kazama, JS McDonough, TS Griffith, RS Hotchkiss, TA Ferguson |
Journal of immunology (Baltimore, Md. : 1950) | 2010 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammation
O Hoffmann, F Zipp, JR Weber |
Journal of Molecular Medicine | 2009 |
Immune cell-mediated liver injury
N Corazza, A Badmann, C Lauer |
Seminars in Immunopathology | 2009 |
Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice
S Ganai, RB Arenas, NS Forbes |
British Journal of Cancer | 2009 |
Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage
N Beraza, Y Malato, LE Sander, M Al-Masaoudi, J Freimuth, D Riethmacher, GJ Gores, T Roskams, C Liedtke, C Trautwein |
Journal of Experimental Medicine | 2009 |
Caspase inhibitors for the treatment of hepatitis C
HC Masuoka, ME Guicciardi, GJ Gores |
Clinics in Liver Disease | 2009 |
The TRAIL to Viral Pathogenesis: The Good, the Bad and the Ugly
Cummins N, Badley A |
Current molecular medicine | 2009 |
Differential roles of JNK in ConA/GalN and ConA-induced liver injury in mice
HM Ni, X Chen, WX Ding, M Schuchmann, XM Yin |
The American Journal of Pathology | 2008 |
Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease
K Takeda, Y Kojima, K Ikejima, K Harada, S Yamashina, K Okumura, T Aoyama, S Frese, H Ikeda, NM Haynes, E Cretney, H Yagita, N Sueyoshi, N Sato, Y Nakanuma, MJ Smyth, K Okumura |
Proceedings of the National Academy of Sciences | 2008 |
Enhancement of glioma radiotherapy and chemotherapy response with targeted antibody therapy against death receptor 5
JB Fiveash, GY Gillespie, PG Oliver, T Zhou, ML Belenky, DJ Buchsbaum |
International journal of radiation oncology, biology, physics | 2008 |
TRAIL deficiency does not rescue impaired CD8+ T cell memory generated in the absence of CD4+ T cell help.
Sacks JA, Bevan MJ |
Journal of immunology (Baltimore, Md. : 1950) | 2008 |
TRAIL-R knockout promotes susceptibility to chronic inflammation and tumorigenesis
Niklas Finnberg, Andres J.P. Klein-Szanto and Wafik S. El-Deiry |
Journal of Clinical Investigation | 2007 |
Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage
C Dunn, M Brunetto, G Reynolds, T Christophides, PT Kennedy, P Lampertico, A Das, AR Lopes, P Borrow, K Williams, E Humphreys, S Afford, DH Adams, A Bertoletti, MK Maini |
Journal of Experimental Medicine | 2007 |
CCR5 Deficiency Drives Enhanced Natural Killer Cell Trafficking to and Activation within the Liver in Murine T Cell-Mediated Hepatitis
MN Ajuebor, Z Wondimu, CM Hogaboam, T Le, AE Proudfoot, MG Swain |
The American Journal of Pathology | 2007 |
Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity
H Malhi, FJ Barreyro, H Isomoto, SF Bronk, GJ Gores |
Gut | 2007 |
Soluble apoptosis molecules in primary biliary cirrhosis: analysis and commitment of the Fas and tumour necrosis factor-related apoptosis-inducing ligand systems in comparison with chronic hepatitis C
N Pelli, A Floreani, F Torre, A Delfino, A Baragiotta, P Contini, M Basso, A Picciotto |
Clinical & Experimental Immunology | 2007 |
Hepatitis C virus infection and apoptosis
Fischer R, Baumert T, Blum HE |
World journal of gastroenterology : WJG | 2007 |
Cytokine-mediated disruption of lymphocyte trafficking, hemopoiesis, and induction of lymphopenia, anemia, and thrombocytopenia in anti-CD137-treated mice.
Niu L, Strahotin S, Hewes B, Zhang B, Zhang Y, Archer D, Spencer T, Dillehay D, Kwon B, Chen L, Vella AT, Mittler RS |
Journal of immunology (Baltimore, Md. : 1950) | 2007 |
Essential Role of TNF family molecule LIGHT as a Cytokine in the Pathogenesis of Hepatitis
Sudarshan Anand, Pu Wang, Kiyoshi Yoshimura, In-Hak Choi, Anja Hilliard, Youhai H. Chen, Chyung-Ru Wang, Richard Schulick, Andrew S. Flies, Dallas B. Flies, Gefeng Zhu, Yanhui Xu, Drew M. Pardoll, Lieping Chen and Koji Tamada |
Journal of Clinical Investigation | 2006 |
TRAIL receptor-mediated Jun kinase activation and Bim phosphorylation critically regulate Fas (CD95)-mediated liver damage and lethality
Nadia Corazza, Sabine Jakob, Corinne Schaer, Steffen Frese, Adrian Keogh, Deborah Stroka, Daniela Kassahn, Ralph Torgler, Christoph Mueller, Pascal Schneider, Thomas Brunner |
Journal of Clinical Investigation | 2006 |
Regulation of Apoptosis by Gram-Positive Bacteria: Mechanistic Diversity and Consequences for Immunity
GC Ulett, EE Adderson |
Current immunology reviews | 2006 |
Mac-1 + Cells Are the Predominant Subset in the Early Hepatic Lesions of Mice Infected with Francisella tularensis
JW Rasmussen, J Cello, H Gil, CA Forestal, MB Furie, DG Thanassi, JL Benach |
Infection and immunity | 2006 |
Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake
B Mundt, T Wirth, L Zender, M Waltemathe, C Trautwein, MP Manns, F Kühnel, S Kubicka |
Gut | 2005 |
Following the TRAIL from hepatitis C virus and alcohol to fatty liver
SC Afford, DH Adams |
Gut | 2005 |
Cleavage of p53-vimentin complex enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of rheumatoid arthritis synovial fibroblasts.
Yang X, Wang J, Liu C, Grizzle WE, Yu S, Zhang S, Barnes S, Koopman WJ, Mountz JD, Kimberly RP, Zhang HG |
The American Journal of Pathology | 2005 |
TRAIL and its receptors as targets for cancer therapy
H Yagita, K Takeda, Y Hayakawa, MJ Smyth, K Okumura |
Cancer Science | 2004 |